Although viral E1E2 heterogeneity is detectable at every stage of clinical infection, sampling of recently infected individuals reveals that a genetic bottleneck occurs upon viral transmission, resulting in highly restricted envelope glycoprotein diversity in a newly infected host. Here, ERVW-1 is linked to infection.